- Health Spotlight's Congenital Adrenal Hyperplasia Insights
- Posts
- Weekly Spotlight - 31.10.24
Weekly Spotlight - 31.10.24
Advocacy for emergency school training; support for intersex health research; biopharmaceutical innovation for rare conditions.
Liam Ball
October 31, 2024 • Estimated Reading Time: 2 minutes
In the News |
Ramsgate Parents Advocate for School Training in Life-Saving Medication |
Ramsgate parents Leah and Louis campaign for school staff training to administer life-saving medication for their children, Jaxon and Annie, who have congenital adrenal hyperplasia. They seek community nurse support to ensure school safety, emphasising the importance of immediate care during emergencies. Their petition has 262 signatures. |
University of Sydney offers scholarship for intersex health research |
The University of Sydney offers a $30,000 scholarship for PhD research on intersex health, focusing on bioethics and health law. This initiative supports the Interconnect Health Research project, aiming to improve healthcare for individuals with innate variations of sex characteristics, promoting ethical and equitable access to care. |
Spruce Biosciences to Present at Healthcare Innovation Conference |
Spruce Biosciences, a biopharmaceutical company, will present at the Guggenheim Securities Healthcare Innovation Conference on 11 November 2024. CEO Javier Szwarcberg will discuss their novel therapies for endocrine and neurological disorders. The presentation will be available via live webcast and archived for 90 days. |
Community |
Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters! |
Health Spotlight’s Congenital Adrenal Hyperplasia is a Contentive publication in the Healthcare division